Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1977 1
1978 2
1980 1
1982 1
1983 2
1994 2
2001 1
2009 1
2011 2
2012 2
2013 3
2014 1
2018 1
2019 2
2020 2
2021 1
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Leg pain and gynecologic malignancy.
Singh L, Stevens EE. Singh L, et al. Among authors: stevens ee. Am J Hosp Palliat Care. 2013 Sep;30(6):594-600. doi: 10.1177/1049909112460422. Epub 2012 Sep 25. Am J Hosp Palliat Care. 2013. PMID: 23015730 Review.
A history of infant feeding.
Stevens EE, Patrick TE, Pickler R. Stevens EE, et al. J Perinat Educ. 2009 Spring;18(2):32-9. doi: 10.1624/105812409X426314. J Perinat Educ. 2009. PMID: 20190854 Free PMC article.
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer.
Rocconi RP, Stevens EE, Bottsford-Miller JN, Ghamande SA, Elder J, DeMars LL, Munkarah A, Aaron P, Stanbery L, Wallraven G, Bognar E, Manley M, Horvath S, Manning L, Walter A, Galanis E, Herzog T, Monk BJ, Coleman RL, Nemunaitis J. Rocconi RP, et al. Among authors: stevens ee. Cancer Gene Ther. 2022 Mar;29(3-4):369-382. doi: 10.1038/s41417-021-00317-5. Epub 2021 Mar 22. Cancer Gene Ther. 2022. PMID: 33753870 Clinical Trial.
Fertility after chemotherapy for testicular cancer.
Drasga RE, Einhorn LH, Williams SD, Patel DN, Stevens EE. Drasga RE, et al. Among authors: stevens ee. J Clin Oncol. 1983 Mar;1(3):179-83. doi: 10.1200/JCO.1983.1.3.179. J Clin Oncol. 1983. PMID: 6199473
Gemogenovatucel-T (Vigil) immunotherapy as maintenance in frontline stage III/IV ovarian cancer (VITAL): a randomised, double-blind, placebo-controlled, phase 2b trial.
Rocconi RP, Grosen EA, Ghamande SA, Chan JK, Barve MA, Oh J, Tewari D, Morris PC, Stevens EE, Bottsford-Miller JN, Tang M, Aaron P, Stanbery L, Horvath S, Wallraven G, Bognar E, Manning L, Nemunaitis J, Shanahan D, Slomovitz BM, Herzog TJ, Monk BJ, Coleman RL. Rocconi RP, et al. Among authors: stevens ee. Lancet Oncol. 2020 Dec;21(12):1661-1672. doi: 10.1016/S1470-2045(20)30533-7. Lancet Oncol. 2020. PMID: 33271095 Clinical Trial.
24 results